Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Gross Margin: 2013-2025

Historic Gross Margin for Theravance Biopharma (TBPH) over the last 13 years, with Sep 2025 value amounting to 100.00%.

  • Theravance Biopharma's Gross Margin changed negligibly% to 100.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q3 2025, Theravance Biopharma's Gross Margin is 100.00%, which was down 0.00% from 100.00% recorded in Q2 2025.
  • Theravance Biopharma's 5-year Gross Margin high stood at 100.00% for Q1 2021, and its period low was 100.00% during Q1 2021.
  • In the last 3 years, Theravance Biopharma's Gross Margin had a median value of 100.00% in 2025 and averaged 100.00%.